BRIAN CASE: Open Payments
NPI 1922294479 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 14 payments from 4 companies in 2025. Trend: 2023 $367 · 2024 $309 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Orexo US, Inc. | 9 | $164 |
| Boston Scientific Corporation | 3 | $89 |
| Abbott Laboratories | 1 | $25 |
| Indivior Inc. | 1 | $17 |
Products named: Zubsolv, EMBLEM MRI S-ICD, ACCOLADE SR, CARDIOMEMS, SUBLOCADE.
Industry payments across IN — which companies pay providers there.
